Urology · Sikeston, MO
NPI
1538258629
Since 2006
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1106 N Main St
Sikeston, MO, 63801
Phone (573) 471-8656
Groups this clinician bills Medicare through
Medicare paid, 2024
$82K
1,181 services
Medicare patients, 2024
497
Average age 73
Drug cost, 2024
$1.3M
4,030 prescriptions
Company payments, 2025
$689
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Animesh Sahai was code 99213 (office e&m - established), 421 times for 275 patients. In total Animesh Sahai billed 1,181 services in 51 codes, and Medicare paid $82K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 421 | 275 | $47.16 | $20K |
| 99214 Office E&M - Established | Office | 235 | 167 | $68.56 | $16K |
| 99204 Office E&M - New | Office | 94 | 94 | $94.80 | $8,912 |
| 99203 Office E&M - New | Office | 71 | 71 | $61.68 | $4,380 |
| 99212 Office E&M - Established | Office | 66 | 60 | $23.39 | $1,543 |
| 52000 Cystourethroscopy | Office | 44 | 42 | $60.23 | $2,650 |
| 99222 Hospital E&M - Initial | Facility | 27 | 25 | $100.25 | $2,707 |
| 52332 Cystourethroscopy | Facility | 20 | 18 | $106.21 | $2,124 |
| 55700 Other Organ Systems | Office | 18 | 18 | $96.90 | $1,744 |
| 55700 Other Organ Systems | Facility | 18 | 18 | $93.58 | $1,684 |
| 76872 Ultrasound - Nonspecific | Facility | 13 | 13 | $24.51 | $319 |
| 52310 Calculus Removal - Urinary | Office | 11 | 11 | $115.29 | $1,268 |
By year: 2022 $82K for 1,151 services; 2023 $72K for 983 services; 2024 $82K for 1,181 services.
Medicare prescription drug claims, 2024
In 2024, the drug Animesh Sahai prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,175 prescriptions and refills. In total Animesh Sahai wrote 4,030 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,175 | 1,694 | 235 | $9,422 |
| Finasteride Generic | 790 | 1,236 | 165 | $4,888 |
| Oxybutynin Chloride Generic | 263 | 343 | 62 | $3,986 |
| Solifenacin Succinate Generic | 257 | 299 | 61 | $9,678 |
| Myrbetriq Mirabegron | 237 | 281 | 48 | $120K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 151 | 151 | 114 | $635 |
| Gemtesa Vibegron | 149 | 188 | 26 | $90K |
| Ciprofloxacin Hcl Generic | 101 | 101 | 89 | $401 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 97 | 97 | 72 | $1,249 |
| Trospium Chloride Er Trospium Chloride | 84 | 100 | 19 | $7,630 |
| Trospium Chloride Generic | 63 | 70 | 14 | $3,781 |
| Xtandi Enzalutamide | 63 | 63 | Under 11 | $928K |
| Tolterodine Tartrate Er Tolterodine Tartrate | 54 | 54 | 12 | $2,629 |
| Diazepam Generic | 44 | 44 | 40 | $37.19 |
| Fesoterodine Fumarate Er Fesoterodine Fumarate | 42 | 44 | 13 | $1,897 |
Brand drugs: 573 claims; generic drugs: 3,457 claims; opioid claims: 155.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Animesh Sahai $689 ($689 in general payments such as food, travel and fees) from 13 companies. The largest payer was Janssen Biotech, Inc. with $119.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 5 | $119 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $102 |
| Boston Scientific Corporation BSX | 1 | $91.77 |
| Endo USA, Inc. | 3 | $71.15 |
| Dendreon Pharmaceuticals LLC | 3 | $59.82 |
| Calyxo, Inc. | 2 | $46.04 |
| Sumitomo Pharma America, Inc. 4506.T | 2 | $45.48 |
| Astellas Pharma US Inc 4503.T | 2 | $45.16 |
| Merck Sharp & Dohme LLC MRK | 2 | $39.25 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $23.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.